NCT07835412Recruiting
A Comparative Study of Patients Undergoing Surgery for Pituitary Neuroendocrine Tumors Detected by Different Ways
Role of Health Screening in Patients Undergoing Surgery for Pituitary Neuroendocrine Tumors: A Multicenter Cohort Study From the National Brain Tumor Registry of China (NBTRC)
Source: ClinicalTrials.gov · Last updated 30 Sept 2026
Brief summary (registry, in English)
This multicenter cohort study is based on the National Brain Tumor Registry of China (NBTRC). It will compare patients who underwent surgery for Pituitary Neuroendocrine Tumors (PitNETs) detected through health screening versus those diagnosed via outpatient consultations. The study will evaluate differences between the two groups in surgical metrics, patient-centered outcomes, and healthcare utilization.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 5000 (estimated)
- First submitted
- 15 Sept 2026
- Start date
- 22 Sept 2026
- Primary completion date
- 30 Sept 2026
- Lead sponsor
- Beijing Tiantan Hospital
- Diseases
- Neuroendocrine tumours, Childhood cancers
- NCT number
- NCT07835412
What you commit to
- Study type: Observational
- Planned participants: 5000
- From 22 Sept 2026 to the primary completion date, 30 Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- The department (health screening or outpatient clinics) where the definitive diagnosis confirmed was missing or unclear
- PitNETs was recurrent or synchronous brain tumors of any histology existed
- Admission was via the emergency department
- Maximum tumor diameter on preoperative MRI were unavailable
- Patients who explicitly declined to participate in this study
Who the study is looking for
- Patients with PitNETs who underwent surgical resection at Beijing Tiantan Hospital from September 1, 2011, to November 30, 2019, together with those recorded in the NBTRC who underwent surgery from December 1, 2019, to December 31, 2021.
Age in the registry: 1 year to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| the National Brain Tumor Registry of China (NBTRC) Coordinator of this site? Confirm its status | Beijing | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.